Foley’s Health Care Industry Team is frequently asked to assist clients in identifying key compliance risks on an industry-wide basis. Foley Partners Maria E. Gonzalez Knavel and Lawrence W. Vernaglia presented our best estimates for the “top 10” compliance risks for hospitals and health systems in 2008. Of course, every hospital has its own unique set of challenges, and the list below is not meant to be exhaustive nor to exclude other issues from compliance review.
- Medicaid — Deficit Reduction Act (DRA) and False Claims Act
- Board of directors involvement — structural issues
- Centers for Medicare & Medicaid Services (CMS) data mining implications
- Recovery audit contractor (RAC) audits and other new predators
- Research, clinical trials billing, time, and effort reporting
- Medicare severity diagnosis related groups
- Present On Admission and Hospital Acquired Conditions
- “Supplemental” and certification/status payments
- Stark Phase III — physician-hospital relations
- Quality
Related Insights
June 3, 2025
Foley Corporate Governance Update
Texas Senate Bill 2337: Protecting Texas Companies and Their Directors, Shareholders and Boards from Proxy Advice Not in the Financial Interests of Shareholders
On June 2, 2025, the Texas Legislature passed Senate Bill 2337, meaningfully regulating proxy advisors like ISS and Glass Lewis when providing proxy voting recommendations concerning Texas companies.
September 25, 2025
Events
Unclaimed Property Roundtable with Delaware State Escheator and Leading Practitioners
June 3, 2025
Health Care Law Today
GLP-1 Receptor Agonists: The Surge of M&A Activity and the Future of Metabolic Health
Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for metabolic disorders, particularly type 2 diabetes and obesity.